NasdaqCM - Nasdaq Real Time Price USD

Rockwell Medical, Inc. (RMTI)

Compare
3.6500 -0.0500 (-1.35%)
At close: October 31 at 4:00 PM EDT
3.6700 +0.02 (+0.55%)
After hours: October 31 at 7:37 PM EDT
Loading Chart for RMTI
DELL
  • Previous Close 3.7000
  • Open 3.6800
  • Bid 3.6400 x 200
  • Ask 3.6700 x 200
  • Day's Range 3.5500 - 3.7300
  • 52 Week Range 1.1600 - 4.5700
  • Volume 181,625
  • Avg. Volume 546,906
  • Market Cap (intraday) 114.657M
  • Beta (5Y Monthly) 1.49
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1500
  • Earnings Date Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.50

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

www.rockwellmed.com

237

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RMTI

View More

Performance Overview: RMTI

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RMTI
93.12%
S&P 500
19.62%

1-Year Return

RMTI
115.98%
S&P 500
36.93%

3-Year Return

RMTI
38.55%
S&P 500
23.89%

5-Year Return

RMTI
85.70%
S&P 500
87.26%

Compare To: RMTI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMTI

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    113.26M

  • Enterprise Value

    115.77M

  • Trailing P/E

    --

  • Forward P/E

    52.08

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.12

  • Price/Book (mrq)

    4.82

  • Enterprise Value/Revenue

    1.23

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.06%

  • Return on Assets (ttm)

    -4.25%

  • Return on Equity (ttm)

    -28.90%

  • Revenue (ttm)

    94.37M

  • Net Income Avi to Common (ttm)

    -4.92M

  • Diluted EPS (ttm)

    -0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.86M

  • Total Debt/Equity (mrq)

    61.18%

  • Levered Free Cash Flow (ttm)

    -2.37M

Research Analysis: RMTI

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 25.83M
Earnings 343k
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

6.00
7.50 Average
3.6500 Current
9.00 High
 

Company Insights: RMTI

People Also Watch